Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • IE • USD
Mallinckrodt plc (MNKKQ) has a consensus analyst rating of Sell, based on 3 analysts covering the stock. Of those, 0 recommend buying, 1 recommend holding, and 2 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.
